Cargando…

Increased circulating microRNA-122 is a biomarker for discrimination and risk stratification in patients defined by sepsis-3 criteria

BACKGROUND: Sepsis is now operationally defined as life-threatening organ dysfunction caused by an infection, identified by an acute change in SOFA-Score of at least two points, including clinical chemistry such as creatinine or bilirubin concentrations. However, little knowledge exists about organ-...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahmel, Tim, Schäfer, Simon T., Frey, Ulrich H., Adamzik, Michael, Peters, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962092/
https://www.ncbi.nlm.nih.gov/pubmed/29782519
http://dx.doi.org/10.1371/journal.pone.0197637
_version_ 1783324837399232512
author Rahmel, Tim
Schäfer, Simon T.
Frey, Ulrich H.
Adamzik, Michael
Peters, Jürgen
author_facet Rahmel, Tim
Schäfer, Simon T.
Frey, Ulrich H.
Adamzik, Michael
Peters, Jürgen
author_sort Rahmel, Tim
collection PubMed
description BACKGROUND: Sepsis is now operationally defined as life-threatening organ dysfunction caused by an infection, identified by an acute change in SOFA-Score of at least two points, including clinical chemistry such as creatinine or bilirubin concentrations. However, little knowledge exists about organ-specific microRNAs as potentially new biomarkers. Accordingly, we tested the hypotheses that micro-RNA-122, the foremost liver-related micro-RNA (miR), 1) discriminates between sepsis and infection, 2) is an early predictor for mortality, and 3) improves the prognostic value of the SOFA-score. METHODS: We analyzed 108 patients with sepsis (infection + increase SOFA-Score ≥2) within the first 24h of ICU admission and as controls 20 patients with infections without sepsis (infection + SOFA-Score ≤1). Total circulating miR was isolated from serum and relative miR-122 expression was measured (using spiked-in cel-miR-54) and associated with 30-day survival. RESULTS: 30-day survival of the sepsis patients was 63%. miR-122 expression was 40-fold higher in non-survivors (p = 0.001) and increased almost 6-fold in survivors (p = 0.013) compared to controls. miR-122 serum-expression discriminated both between sepsis vs. infection (AUC 0.760, sensitivity 58.3%, specificity 95%) and survivors vs. non-survivors (AUC 0.728, sensitivity 42.5%, specificity 94%). Multivariate Cox-regression analysis revealed miR-122 (HR 4.3; 95%-CI 2.0–8.9, p<0.001) as independent prognostic factor for 30-day mortality. Furthermore, the predictive value for 30-day mortality of the SOFA-Score (AUC 0.668) was improved by adding miR-122 (AUC 0.743; net reclassification improvement 0.37, p<0.001; integrated discrimination improvement 0.07, p = 0.007). CONCLUSIONS: Increased miR-122 serum concentration supports the discrimination between infection and sepsis, is an early and independent risk factor for 30-day mortality, and improves the prognostic value of the SOFA-Score, suggesting a potential role for miR-122 in sepsis-related prediction models.
format Online
Article
Text
id pubmed-5962092
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-59620922018-06-02 Increased circulating microRNA-122 is a biomarker for discrimination and risk stratification in patients defined by sepsis-3 criteria Rahmel, Tim Schäfer, Simon T. Frey, Ulrich H. Adamzik, Michael Peters, Jürgen PLoS One Research Article BACKGROUND: Sepsis is now operationally defined as life-threatening organ dysfunction caused by an infection, identified by an acute change in SOFA-Score of at least two points, including clinical chemistry such as creatinine or bilirubin concentrations. However, little knowledge exists about organ-specific microRNAs as potentially new biomarkers. Accordingly, we tested the hypotheses that micro-RNA-122, the foremost liver-related micro-RNA (miR), 1) discriminates between sepsis and infection, 2) is an early predictor for mortality, and 3) improves the prognostic value of the SOFA-score. METHODS: We analyzed 108 patients with sepsis (infection + increase SOFA-Score ≥2) within the first 24h of ICU admission and as controls 20 patients with infections without sepsis (infection + SOFA-Score ≤1). Total circulating miR was isolated from serum and relative miR-122 expression was measured (using spiked-in cel-miR-54) and associated with 30-day survival. RESULTS: 30-day survival of the sepsis patients was 63%. miR-122 expression was 40-fold higher in non-survivors (p = 0.001) and increased almost 6-fold in survivors (p = 0.013) compared to controls. miR-122 serum-expression discriminated both between sepsis vs. infection (AUC 0.760, sensitivity 58.3%, specificity 95%) and survivors vs. non-survivors (AUC 0.728, sensitivity 42.5%, specificity 94%). Multivariate Cox-regression analysis revealed miR-122 (HR 4.3; 95%-CI 2.0–8.9, p<0.001) as independent prognostic factor for 30-day mortality. Furthermore, the predictive value for 30-day mortality of the SOFA-Score (AUC 0.668) was improved by adding miR-122 (AUC 0.743; net reclassification improvement 0.37, p<0.001; integrated discrimination improvement 0.07, p = 0.007). CONCLUSIONS: Increased miR-122 serum concentration supports the discrimination between infection and sepsis, is an early and independent risk factor for 30-day mortality, and improves the prognostic value of the SOFA-Score, suggesting a potential role for miR-122 in sepsis-related prediction models. Public Library of Science 2018-05-21 /pmc/articles/PMC5962092/ /pubmed/29782519 http://dx.doi.org/10.1371/journal.pone.0197637 Text en © 2018 Rahmel et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Rahmel, Tim
Schäfer, Simon T.
Frey, Ulrich H.
Adamzik, Michael
Peters, Jürgen
Increased circulating microRNA-122 is a biomarker for discrimination and risk stratification in patients defined by sepsis-3 criteria
title Increased circulating microRNA-122 is a biomarker for discrimination and risk stratification in patients defined by sepsis-3 criteria
title_full Increased circulating microRNA-122 is a biomarker for discrimination and risk stratification in patients defined by sepsis-3 criteria
title_fullStr Increased circulating microRNA-122 is a biomarker for discrimination and risk stratification in patients defined by sepsis-3 criteria
title_full_unstemmed Increased circulating microRNA-122 is a biomarker for discrimination and risk stratification in patients defined by sepsis-3 criteria
title_short Increased circulating microRNA-122 is a biomarker for discrimination and risk stratification in patients defined by sepsis-3 criteria
title_sort increased circulating microrna-122 is a biomarker for discrimination and risk stratification in patients defined by sepsis-3 criteria
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962092/
https://www.ncbi.nlm.nih.gov/pubmed/29782519
http://dx.doi.org/10.1371/journal.pone.0197637
work_keys_str_mv AT rahmeltim increasedcirculatingmicrorna122isabiomarkerfordiscriminationandriskstratificationinpatientsdefinedbysepsis3criteria
AT schafersimont increasedcirculatingmicrorna122isabiomarkerfordiscriminationandriskstratificationinpatientsdefinedbysepsis3criteria
AT freyulrichh increasedcirculatingmicrorna122isabiomarkerfordiscriminationandriskstratificationinpatientsdefinedbysepsis3criteria
AT adamzikmichael increasedcirculatingmicrorna122isabiomarkerfordiscriminationandriskstratificationinpatientsdefinedbysepsis3criteria
AT petersjurgen increasedcirculatingmicrorna122isabiomarkerfordiscriminationandriskstratificationinpatientsdefinedbysepsis3criteria